Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

Legislation under consideration in Trenton could modernize the scope of access to modern eye care in New Jersey.

ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A.

Background Normal tension glaucoma ... right eye was used for statistical analysis. Results In 41 right eyes, the mean pre-study IOP was 14.3 ± 3.4 mmHg while on 1.5 ± 0.8 eye drops.

Pink eye, or conjunctivitis, is the inflammation of the conjunctiva, or the thin layer of membrane that protects your eye. Pink eye, which can make the white part of one or both of your eyes look ...

Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

OC134 is an eye drop medicine candidate indicated for the topical treatment of moderate to severe allergic conjunctivitis, a condition for which a suitable non-steroidal topical ocular treatment, does ...

The biodegradable implant offers sustained drug delivery for up to 26 weeks, addressing challenges of patient adherence and improving glaucoma treatment outcomes. A Korean study identified ...

233201029141. Forever iVision helps us take a proactive step to protect and support our eye health by improving visual processing speed, alleviating eye conditions such as glaucoma, eye infections, ...

Cataracts are a common yet often misunderstood eye condition and remain one of the leading causes of vision impairment ...